Apex Biotechnology Corp (1733) — Cash Flow Quality Index
Apex Biotechnology Corp (1733) has a Cash Flow Quality Index of 0.18x as of September 2025. Operating cash flow of NT$5.19 Million is below net income of NT$29.21 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 1733 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Apex Biotechnology Corp Cash Flow Quality Index (2002–2024)
Historical Cash Flow Quality Index for Apex Biotechnology Corp across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 1733 cash flow conversion.
Annual Cash Flow Quality Index for Apex Biotechnology Corp (2002–2024)
Year-by-year earnings quality comparison for Apex Biotechnology Corp.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.15x | NT$328.67 Million | NT$153.13 Million | ▲ +31.3% |
| 2023 | 1.63x | NT$230.39 Million | NT$140.96 Million | ▲ +1125.5% |
| 2022 | 0.13x | NT$26.62 Million | NT$199.57 Million | ▼ -86.3% |
| 2021 | 0.97x | NT$179.87 Million | NT$184.94 Million | ▼ -61.7% |
| 2020 | 2.54x | NT$280.60 Million | NT$110.61 Million | ▼ -10.6% |
| 2019 | 2.84x | NT$462.52 Million | NT$162.94 Million | ▲ +577.8% |
| 2018 | 0.42x | NT$67.57 Million | NT$161.34 Million | ▼ -33.8% |
| 2017 | 0.63x | NT$70.83 Million | NT$111.97 Million | ▼ -88.9% |
| 2016 | 5.72x | NT$298.06 Million | NT$52.09 Million | ▲ +277.3% |
| 2015 | 1.52x | NT$472.15 Million | NT$311.29 Million | ▲ +80.8% |
| 2014 | 0.84x | NT$267.60 Million | NT$318.94 Million | ▼ -26.2% |
| 2013 | 1.14x | NT$484.77 Million | NT$426.38 Million | ▲ +16.5% |
| 2012 | 0.98x | NT$509.67 Million | NT$522.45 Million | ▲ +87.9% |
| 2011 | 0.52x | NT$273.45 Million | NT$526.62 Million | ▼ -49.4% |
| 2010 | 1.03x | NT$465.59 Million | NT$453.95 Million | ▼ -14.4% |
| 2009 | 1.20x | NT$391.29 Million | NT$326.48 Million | ▲ +13.6% |
| 2008 | 1.06x | NT$299.96 Million | NT$284.29 Million | ▲ +16.5% |
| 2007 | 0.91x | NT$364.62 Million | NT$402.53 Million | ▼ -24.2% |
| 2006 | 1.19x | NT$363.71 Million | NT$304.41 Million | ▼ -9.5% |
| 2004 | 1.32x | NT$218.54 Million | NT$165.49 Million | ▼ -29.4% |
| 2003 | 1.87x | NT$302.25 Million | NT$161.60 Million | ▲ +137.0% |
| 2002 | 0.79x | NT$79.49 Million | NT$100.74 Million | — |